Literature DB >> 7055818

Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.

F M Sirotnak, J I DeGraw, P L Chello, D M Moccio, D M Dorick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7055818

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic Options for Aggressive T-Cell Lymphomas.

Authors:  Jennifer K Lue; Anna Kress; Jennifer E Amengual
Journal:  Curr Hematol Malig Rep       Date:  2017-08       Impact factor: 3.952

2.  New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties.

Authors:  F M Sirotnak; J I DeGraw; D M Moccio; L L Samuels; L J Goutas
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models.

Authors:  F M Sirotnak; J I DeGraw; F A Schmid; L J Goutas; D M Moccio
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Phase II trial of 10 deaza-aminopterin in patients with bladder cancer.

Authors:  T Ahmed; A Yagoda; H I Scher; C Sternberg; R C Watson
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

Review 5.  Biological and biochemical properties of new anticancer folate antagonists.

Authors:  D W Fry; R C Jackson
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

Authors:  Enrica Marchi; Owen A O'Connor
Journal:  Ther Adv Hematol       Date:  2012-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.